Aromatase inhibitors

Fourth Power Labs Announces National Launch of Exclusive Hemp-Derived, THC-Free CBD Products for Medical Professionals and Their Patients

Retrieved on: 
Wednesday, July 14, 2021
Drugs, Euphoriants, Appetite stimulants, Entheogens, Psychoactive drugs, Medical specialties, Antiemetics, Aromatase inhibitors, Tetrahydrocannabinol, Hemp, Cannabis, Cannabidiol

TULSA, Okla., July 13, 2021 /PRNewswire/ -- Fourth Power Labs today announced it will begin offering pharmaceutical-grade hemp-derived, THC-free CBD products to Medical Professionals and their patients across the United States, effective immediately.Their products are now available for purchase through its dedicated salesforce and e-commerce website www.FourthPowerLabs.com .

Key Points: 
  • TULSA, Okla., July 13, 2021 /PRNewswire/ -- Fourth Power Labs today announced it will begin offering pharmaceutical-grade hemp-derived, THC-free CBD products to Medical Professionals and their patients across the United States, effective immediately.Their products are now available for purchase through its dedicated salesforce and e-commerce website www.FourthPowerLabs.com .
  • Fourth Power Labs was founded in 2019 by a team of pharmaceutical industry veterans with decades of experience in highly regulated FDA environments.
  • To learn more about Fourth Power Labs, its market-leading, quality CBD products, and its commitment to Medical Professionals and their patients, please visit www.FourthPowerLabs.com or call 800-375-0009.
  • Fourth Power Labs, a 100% employee-owned and operated business based in Tulsa, Oklahoma, serves the market with a broad spectrum hemp-derived THC-free CBD product line that delivers unmatched quality created specifically for Medical Professionals and their patients.

Edison Investment Research Limited: Medlab Clinical (MDC): Initiation - Novel drug delivery and cannabinoids against pain

Retrieved on: 
Monday, July 12, 2021
Drugs, Euphoriants, Antiemetics, Appetite stimulants, Entheogens, Aromatase inhibitors, Psychoactive drugs, Medical specialties, Tetrahydrocannabinol, Thomas Edison, Cannabinoid

Medlab's lead product is NanaBis, a combination of THC and CBD (1:1) cannabinoids encapsulated in NanoCelle particles, which enable a convenient buccal spray formulation.

Key Points: 
  • Medlab's lead product is NanaBis, a combination of THC and CBD (1:1) cannabinoids encapsulated in NanoCelle particles, which enable a convenient buccal spray formulation.
  • Once the product reformulation is completed (guidance is eight to 10 months), NanaBis will re-enter clinical development (potentially Phase III) as a fully synthetic, non-opioid pain relief drug optimised with proprietary delivery technology aimed at a vast market.
  • About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors.
  • Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector.

Tauriga Sciences Inc. Prepares for Major Upcoming Product Launch and Introduces Expanded Tauri-Gummies™ Product Line

Retrieved on: 
Thursday, May 27, 2021
Drugs, Aromatase inhibitors, Branches of biology, Psychoactive drugs, Euphoriants, Orphan drugs, Gummy candy, Tetrahydrocannabinol, Provisional application, Melatonin, Patent application, Cannabis strain

The Company is also planning a June 2021 launch of its expanded and enhanced Tauri-Gummies product line.This product launch will include: Original 25mg CBD infused gum drops (re-formulated without artificial colors), 25mg Delta 8 THC infused Blue Raspberry gummies, and 25mg Delta 8 THC + Melatonin + infused Wild Blueberry gummies.

Key Points: 
  • The Company is also planning a June 2021 launch of its expanded and enhanced Tauri-Gummies product line.This product launch will include: Original 25mg CBD infused gum drops (re-formulated without artificial colors), 25mg Delta 8 THC infused Blue Raspberry gummies, and 25mg Delta 8 THC + Melatonin + infused Wild Blueberry gummies.
  • Please visit our corporate website, for additional information, as well as inquiries, athttp://www.tauriga.com
    Complementary to the Companys retail business, is its ongoing Pharmaceutical Development initiative.
  • Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.The Patent, filed with the U.S.P.T.O.
  • Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances.

NEXT SUPER STOCKS on The Move: Tetra Bio-Pharma, Relay Medical, Victory Square Technologies, and Red Light Holland

Retrieved on: 
Friday, May 7, 2021
Branches of biology, Clinical medicine, Medicine, Appetite stimulants, Antiemetics, Entheogens, Euphoriants, Aromatase inhibitors, Tetrahydrocannabinol, Vomiting, Nausea, Bitly

REDUVO is a synthetic THC-based soft gel capsule indicated in severe nausea and vomiting associated with cancer chemotherapy.

Key Points: 
  • REDUVO is a synthetic THC-based soft gel capsule indicated in severe nausea and vomiting associated with cancer chemotherapy.
  • A highlight of the presentation was a video demo of the company\xe2\x80\x99s rapid testing and tracking platform for infectious diseases, including COVID-19.
  • iMicrodose Packs powered by Red Light Holland are now available in 144% more locations than previously announced.
  • Full disclaimer, and relevant SEC 17B disclosures here: http://bit.ly/39kkE7K\nAbout Wall Street Reporter\xe2\x80\x99s Next Super Stock conference:\nWall Street Reporter\'s NEXT SUPER STOCK Live!

Veru Announces the Presentation of Positive Phase 2 Clinical Data of Enobosarm in AR+ER+HER2- Metastatic Breast Cancer Patients that Have Progressed on Estrogen Blocking Agents and CDK 4/6 Inhibitor at the ESMO Breast Cancer Congress 2021

Retrieved on: 
Wednesday, May 5, 2021
Chemical compounds, Branches of biology, Drugs, Protein kinase inhibitors, Piperazines, Aromatase inhibitors, Progonadotropins, Cyclin-dependent kinase 4, Oncogenes, Letrozole, Breast cancer, Nonsteroidal

Patients who have metastatic breast cancers that progress on estrogen receptor blocking agent and CDK4/6 inhibitor therapies are a group in which we need to define the most optimal drug treatment.

Key Points: 
  • Patients who have metastatic breast cancers that progress on estrogen receptor blocking agent and CDK4/6 inhibitor therapies are a group in which we need to define the most optimal drug treatment.
  • Enobosarm is in clinical development for the treatment of metastatic ER+HER2- breast cancer patients whose disease has progressed after treatment with a nonsteroidal aromatase inhibitor (anastrozole or letrozole), fulvestrant, and a CDK4/6 inhibitor.
  • In the U.S., FC2 is available by prescription through multiple third-party telemedicine and internet pharmacy providers and retail pharmacies.
  • An NDA was filed by FDA in April 2021 with a PDUFA date in December 2021.

Pure Craft CBD Launches Vegan, Nano-Infused Delta-8 THC Gummies

Retrieved on: 
Tuesday, April 20, 2021
Drugs, Aromatase inhibitors, Branches of biology, Psychoactive drugs, Euphoriants, Orphan drugs, Cannabis, Appetite stimulants, Tetrahydrocannabinol, Melatonin, Gummy candy

b'SAN DIEGO, April 20, 2021 /PRNewswire/ --Pure Craft CBD, a CBD brand that harnesses nanotechnology to make premium bio-available products, is launching Delta-8 THC gummies in response to growing consumer demand.

Key Points: 
  • b'SAN DIEGO, April 20, 2021 /PRNewswire/ --Pure Craft CBD, a CBD brand that harnesses nanotechnology to make premium bio-available products, is launching Delta-8 THC gummies in response to growing consumer demand.
  • All Pure Craft CBD products are vegan and come with a third-party lab Certificates of Analysis (COA), so consumers know exactly what\'s in them and how they were tested.\nTheNano-Infused Delta-8 Gummies are each infused with 25mg of Pure Craft CBD\'s nano-optimized Delta-8 THC.
  • "\nPure Craft CBD also recently launched Immune Boost CBD gummies, a vegan product infused with 25mg of Pure Craft CBD\'s nano-optimized broad-spectrum CBD.
  • Its product line includes nano-optimized broad spectrum water-soluble CBD tinctures along with soft gels, vegan gummies, CBD with melatonin, CBD pet tincture, and CBD broad spectrum oil.

CBD Giant Premium Jane Introduces Novel Sleep-Aid Formula With CBN, GABA

Retrieved on: 
Thursday, April 1, 2021
Receptor agonists, Branches of biology, Drugs, Cannabinoids, Natural phenols, Orphan drugs, Aromatase inhibitors, Medicinal plants, Cannabinol, Melatonin, Chamomile, CBN

SCOTTSDALE, Arizona, April 1, 2021 /PRNewswire/ --American CBD giant Premium Jane has introduced a new range of infused products that are specifically engineered to help individuals improve their nightly sleep patterns.

Key Points: 
  • SCOTTSDALE, Arizona, April 1, 2021 /PRNewswire/ --American CBD giant Premium Jane has introduced a new range of infused products that are specifically engineered to help individuals improve their nightly sleep patterns.
  • The products contain a novel formulation of 25mg CBD extract, as well as infused amounts of CBN, GABA, melatonin, and chamomile.
  • The inclusion of CBN (cannabinol) is particularly novel across the greater CBD market, with few brands utilizing the little-known cannabinoid.
  • "It's been an ongoing goal of our development team to formulate a unique, specifically-engineered sleep-aid formula," says Premium Jane CEO Jeff Yauck.

Hemp Bombs® Expands Product Line of Award-Winning CBD Edibles with New Gummy Flavors, Refreshed CBD Max Chill Shot and CBD Capsules

Retrieved on: 
Friday, March 19, 2021
Drugs, Branches of biology, Health sciences, Entheogens, Euphoriants, Orphan drugs, Appetite stimulants, Aromatase inhibitors, Cannabis, Melatonin, Bacterial capsule, Hemp

The newest additions to the award-winning lineup of Hemp Bombs CBD gummies include its Immune Support CBD Gummies with 50mg of elderberry extract and 15mg of CBD in each gummy.

Key Points: 
  • The newest additions to the award-winning lineup of Hemp Bombs CBD gummies include its Immune Support CBD Gummies with 50mg of elderberry extract and 15mg of CBD in each gummy.
  • Following its "Year of More" in 2020, Hemp Bombs CBD Capsules now include more capsules per package for the same price as the previously available sizes.
  • Original CBD Capsules contain 15mg of CBD per capsule, High-Potency CBD Capsules feature 30mg of CBD per capsule and Sleep CBD Capsules contain 15mg of CBD along with 5mg of the sleep aid melatonin in each capsule.
  • Refreshed for 2021, Hemp Bombs CBD Max Chill Shot now features a new raspberry dream flavor with 100mg of CBD in a 2.5-fluid ounce bottle.

World Pharmaceutical Cannabis Report - Existing Products Set for Growth Rates of 150% between 2020 and 2024

Retrieved on: 
Thursday, March 11, 2021
Drugs, Appetite stimulants, Entheogens, Euphoriants, Cannabis, Health care, Amorphous solids, Aromatase inhibitors, Dronabinol, Nabiximols, Pharmaceutical industry in China, GW Pharmaceuticals

DUBLIN, March 11, 2021 /PRNewswire/ -- The "The Impact Series: The Pharmaceutical Cannabis Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 11, 2021 /PRNewswire/ -- The "The Impact Series: The Pharmaceutical Cannabis Report" report has been added to ResearchAndMarkets.com's offering.
  • However, pharmaceutical cannabis products such as Epidyolex, Sativex and Dronabinol have become serious alternatives to traditional pharmaceuticals and are beginning to shift how the pharma industry approaches cannabis.
  • Existing pharmaceutical cannabis products will achieve growth rates of 150% between 2020 and 2024 to reach total value sales just shy of US$2 billion.
  • Consumer insights, detailed analysis and market intelligence allow you to determine the best strategies surrounding the pharmaceutical cannabis market.

Florida CBD Regulatory Report 2020 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 11, 2021
Alternative medicine, Health, Euphoriants, Drugs, Appetite stimulants, Entheogens, Psychoactive drugs, Antiemetics, Branches of biology, Aromatase inhibitors, Tetrahydrocannabinol, Cannabis, Cannabinoid, Hemp

The "CBD Regulatory Report: Florida" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "CBD Regulatory Report: Florida" report has been added to ResearchAndMarkets.com's offering.
  • Hemp-derived cannabinoids (including CBD) are not a controlled substance or adulterant.
  • This means that pure CBD and THC-free full-spectrum extracts can be sold in the state.
  • However, the FDACS has warned that "the CBD products being sold in Florida are unregulated, untested and without standards on what consumers are putting into their bodies.